Advanced search
Start date
Betweenand

Metastasis evaluation by ROCK-1 and miR-17 in breast cancer, in response to the treatment with melatonin and curcumin

Grant number: 12/12114-8
Support type:Scholarships abroad - Research Internship - Post-doctor
Effective date (Start): September 01, 2012
Effective date (End): July 31, 2013
Field of knowledge:Agronomical Sciences - Veterinary Medicine - Animal Pathology
Principal Investigator:Debora Aparecida Pires de Campos Zuccari
Grantee:Thaiz Ferraz Borin
Supervisor abroad: Ali Syed Arbab
Home Institution: Faculdade de Medicina de São José do Rio Preto (FAMERP). Secretaria de Desenvolvimento Econômico (São Paulo - Estado). São José do Rio Preto , SP, Brazil
Research place: Henry Ford Health System, United States  
Associated to the scholarship:11/20850-3 - Metastasis evaluation in vitro and in vivo mediated by ROCK-1 and miR-17 in breast cancer, in response to the treatment with melatonin and curcumin, BP.PD

Abstract

Breast cancer represents the most common cancer among women with a high mortality rate mainly due to the intense tumor growth and metastatic potential. The skeletal metastatic cells have a weak structure and low anchoring allows the invasiveness of cells. Both cell migration and anchorage in the substrate occur through rearrangements of the actin cytoskeleton and cell processes are regulated by external signals and intracellular effectors, including the protein associated with Rho-kinase (ROCK). The expression of ROCK is therefore related to metastasis, and its gene expression modulated by miRNAs. The miR-17 has been shown to modulate proliferation, apoptosis and metastasis in breast cancer. To control these effects, studies with melatonin (a hormone secreted by the pineal gland) and curcumin (a component of the extract of Curcuma longa L) refer to them, anti-metastatic and anti-oncostatic action. The objective of this study is to evaluate in vivo antimetastatic response mediated by ROCK and miR-17 by melatonin and curcumin in breast cancer. The molecular expression of miR-17 will be verified by real-time PCR, and the ROCK will have its molecular and protein expression assessed by real-time PCR and immunohostochemistry, respectively. In addition, it will be done the technique of computed tomography (SPECT) using Tc-99m-MDP and Tc-99m-Glucarate for assessing the extent of metastasis in animal models. The data obtained in this study may explain the likely benefits of the use of melatonin and curcumin as therapeutic agents in the treatment of breast cancer, reducing invasiveness and metastasis occurrence. (AU)

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
BORIN, THAIZ FERRAZ; ARBAB, ALI SYED; GELALETI, GABRIELA BOTTARO; FERREIRA, LIVIA CARVALHO; MOSCHETTA, MARINA GOBBE; JARDIM-PERASSI, BRUNA VICTORASSO; ISKANDER, A. S. M.; VARMA, NADIMPALLI RAVI S.; SHANKAR, ADARSH; COIMBRA, VERENA BENEDICK; FABRI, VANESSA ALVES; DE OLIVEIRA, JULIANA GARCIA; PIRES DE CAMPOS ZUCCARI, DEBORA APARECIDA. Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression. Journal of Pineal Research, v. 60, n. 1, p. 3-15, JAN 2016. Web of Science Citations: 50.
BORIN, THAIZ FERRAZ; ZUCCARI, DEBORA A. P. C.; JARDIM-PERASSI, BRUNA V.; FERREIRA, LIVIA C.; ISKANDER, A. S. M.; VARMA, NADIMPALLI RAVI S.; SHANKAR, ADARSH; GUO, AUSTIN M.; SCICLI, GUILLERMO; ARBAB, ALI S. HET0016, a Selective Inhibitor of 20-HETE Synthesis, Decreases Pro-Angiogenic Factors and Inhibits Growth of Triple Negative Breast Cancer in Mice. PLoS One, v. 9, n. 12 DEC 30 2014. Web of Science Citations: 16.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.